![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 2976 |
FusionGeneSummary for ASH1L_SPRR2G |
![]() |
Fusion gene information | Fusion gene name: ASH1L_SPRR2G | Fusion gene ID: 2976 | Hgene | Tgene | Gene symbol | ASH1L | SPRR2G | Gene ID | 55870 | 6706 |
Gene name | ASH1 like histone lysine methyltransferase | small proline rich protein 2G | |
Synonyms | ASH1|ASH1L1|KMT2H|MRD52 | - | |
Cytomap | 1q22 | 1q21.3 | |
Type of gene | protein-coding | protein-coding | |
Description | histone-lysine N-methyltransferase ASH1LASH1-like proteinabsent small and homeotic disks protein 1 homologash1 (absent, small, or homeotic)-likelysine N-methyltransferase 2Hprobable histone-lysine N-methyltransferase ASH1L | small proline-rich protein 2GSPR-2G | |
Modification date | 20180519 | 20180519 | |
UniProtAcc | Q9NR48 | Q9BYE4 | |
Ensembl transtripts involved in fusion gene | ENST00000368346, ENST00000392403, ENST00000548830, | ENST00000368748, | |
Fusion gene scores | * DoF score | 27 X 14 X 13=4914 | 3 X 2 X 3=18 |
# samples | 30 | 3 | |
** MAII score | log2(30/4914*10)=-4.03386345186628 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: ASH1L [Title/Abstract] AND SPRR2G [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ASH1L | GO:0097676 | histone H3-K36 dimethylation | 26002201 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | BLCA | TCGA-DK-A6B1-01A | ASH1L | chr1 | 155408118 | - | SPRR2G | chr1 | 153122607 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-5UTR | ENST00000368346 | ENST00000368748 | ASH1L | chr1 | 155408118 | - | SPRR2G | chr1 | 153122607 | - |
5CDS-5UTR | ENST00000392403 | ENST00000368748 | ASH1L | chr1 | 155408118 | - | SPRR2G | chr1 | 153122607 | - |
intron-5UTR | ENST00000548830 | ENST00000368748 | ASH1L | chr1 | 155408118 | - | SPRR2G | chr1 | 153122607 | - |
Top |
FusionProtFeatures for ASH1L_SPRR2G |
![]() |
Hgene | Tgene |
ASH1L | SPRR2G |
Histone methyltransferase specifically methylating 'Lys-36' of histone H3 (H3K36me). {ECO:0000269|PubMed:21239497}. | Cross-linked envelope protein of keratinocytes. It is akeratinocyte protein that first appears in the cell cytosol, butultimately becomes cross-linked to membrane proteins bytransglutaminase. All that results in the formation of aninsoluble envelope beneath the plasma membrane (By similarity).{ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for ASH1L_SPRR2G |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for ASH1L_SPRR2G |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
ASH1L | HIST1H3A, H3F3A, SMAD7, THAP7, MORF4L1, PARD6A, SIKE1, MORF4L2, NXF2, CDX1 | SPRR2G | SUZ12 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ASH1L_SPRR2G |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for ASH1L_SPRR2G |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | ASH1L | C0023903 | Liver neoplasms | 1 | CTD_human |